SMTL ID : 6x5y.1 (1 other biounit)

IDO1 in complex with compound 4

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.65 Å

Oligo State

monomer

Ligands

1 x URJ: 4-fluoro-N-{1-[5-(2-methylpyrimidin-4-yl)-5,6,7,8-tetrahydro-1,5-naphthyridin-2-yl]cyclopropyl}benzamide(Non-covalent)

URJ.1: 19 residues within 4Å: Chain A: Y.117, C.120, V.121, F.154, S.158, V.161, E.162, I.208, L.225, G.253, S.254, A.255, S.258, V.260, F.261, L.330, L.333, R.334, H.337 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:Y.117, A:V.121, A:F.154, A:F.154, A:V.161, A:I.208, A:L.225, A:A.255, A:V.260, A:L.330 Hydrogen bonds: A:S.158, A:S.158 pi-Stacking: A:F.261, A:H.337

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hopkins, B. et al., Utilization of MetID and Structural Data to Guide Placement of Spiro and Fused Cyclopropyl Groups for the Synthesis of Low Dose IDO1 Inhibitors. To Be Published

Release Date

2021-06-02

Peptides

Indoleamine 2,3-dioxygenase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Indoleamine 2,3-dioxygenase 1

Related Entries With Identical Sequence